AbbVie scores a key win in Alzheimer's drug patent suit
A California federal appeals court on Thursday let AbbVie off the hook from a whistleblower lawsuit alleging the company held fraudulent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
